MedTrace Logo

Device-detected Paroxysmal Atrial Fibrillation

NCT02442505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2019-04-19

No results posted yet for this study

Summary

This study will use an automated blood pressure monitor (Microlife WatchBP03) with an inbuilt algorithm to detect atrial fibrillation (an irregular heart rhythm) in patients with an implanted pacemaker who have previously documented paroxysmal (intermittent) atrial fibrillation. This study will compare the Microlife device detected atrial fibrillation episodes to the pacemaker detected atrial fibrillation episodes.

Conditions

Interventions

DEVICE

Microlife WatchBP03 device

Microlife WatchBP03 device which is an automated oscillometric device using a new algorithm to detect atrial fibrillation

Sponsors & Collaborators

  • Sandwell & West Birmingham Hospitals NHS Trust

    collaborator OTHER

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Gregory YH Lip, MD · University of Birmingham

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02442505 on ClinicalTrials.gov